M T Bink-Boelkens Selected Research

Leukemia

7/2000

Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M T Bink-Boelkens Research Topics

Disease

1	Cardiomyopathies (Cardiomyopathy) 12/2000
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2000
1	Cardiotoxicity 07/2000
1	Leukemia 07/2000

Drug/Important Bio-Agent (IBA)

1	Carnitine (L-Carnitine)FDA LinkGeneric 12/2000
1	3-methylcrotonyl CoA carboxylase 1 deficiencyIBA 12/2000
1	Daunorubicin (Cerubidine)FDA LinkGeneric 07/2000

Therapy/Procedure

1	Therapeutics 12/2000
1	Aftercare (After-Treatment) 07/2000